chrisvoncsefalvay/vaers-outcomes huggingface dataset:
excruciating pain in his hips, lasted about 8 minutes, then wore off; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (excruciating pain in his hips, lasted about 8 minutes, then wore off) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ARTHRALGIA (excruciating pain in his hips, lasted about 8 minutes, then wore off). At the time of the report, ARTHRALGIA (excruciating pain in his hips, lasted about 8 minutes, then wore off) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported No treatment medications were reported
arm swell; injection site is black; warm to touch at injection site; soreness in arm; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (arm swell), INJECTION SITE REACTION (injection site is black), INJECTION SITE WARMTH (warm to touch at injection site) and PAIN IN EXTREMITY (soreness in arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (arm swell), INJECTION SITE REACTION (injection site is black), INJECTION SITE WARMTH (warm to touch at injection site) and PAIN IN EXTREMITY (soreness in arm). At the time of the report, PERIPHERAL SWELLING (arm swell), INJECTION SITE REACTION (injection site is black), INJECTION SITE WARMTH (warm to touch at injection site) and PAIN IN EXTREMITY (soreness in arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.        No relevant concomitant medications were reported. No treatment was reported
On March 15, 2021 I had Flu like symptoms, including general malaise, low fever, body aches, fatigue, stomach cramps, diarrhea.  Injection site on arm extremely sore.  All resolved except diarrhea and fever by March 17, 2021.  GI symptoms of escalating diarrhea, nausea, fever, fatigue continued until a severe flare of ulcerative colitis was diagnosed and I was hospitalized from May 1 - May 10, 2021.  I previously had been in complete remission since 2015.  I am convinced that the Moderna vaccine caused this flare up.
Pt was in the hospital when he called us.  He called to inform us he was just diagnosed with myocarditis.  End of conversation with patient.  Was not able to get any other information from patient.
About 7 weeks after my second dose of the Pfizer vaccine, the hair on my head began to fall out.  After about 3 weeks 80-90% of the hair on my head was gone.  A biopsy performed by my dermatologist  determined the condition to be alopecia areata.   Normally, alopecia areata is found in much younger persons and results in hair loss in a much smaller portion of the scalp.  I experienced no other associated factors linked to alopecia areata other than the change of medication (taking the Pfizer vaccine).
after 15 min observation period the patient began to feel tightness in his throat and lightheadedness. Initial vitals- BP- 160/85 HR-65 RR- 20 T-97.3  O2Sat 100% on room air. lungs clear to auscultation. patient in no respiratory distress, postenior pharynx/ Uvula without swelling  vital signs prior to being transferred to ER: BP-147/72 P-65 02SAT- 100% on room air RR-20
: Details --HPV vaccine was given in R del. Right after injection pt complained about discomfort in R side of neck, then stated his throat felt funny. Felt like he had food caught in throat. Pt not in distress. Had pt lay down with father by his side, while I went to get Dr. Dr took over care.  1054-Notified that pt is having reaction to HPV vaccine. Pt complaining of throat closing up.  1055-Epipen 0.3mg given IM on left thigh Lot number 9FN767 exp 5/21. RA sats at 100%. 1059-EMS contacted 1104-EMS arrived at the clinic. 1104- Benadryl 50mg given on right arm IM Lot number 6123907 exp 3/22 by LPN. 1107-Pulse remains at 100% RA, HR of 96. Pt is awake, alert, and interacting with staff. Dad and sister remains at bedside. 1110-Continues to monitor condition. Dr. remains at bedside. 1114-Pt transported to hospital via EMS transport with dad and sister.
I was fine until Friday morning when I woke up. I had an intense headache, body aches, chills, and soreness at the shot site. Similar if not worse than when I had COVID-19 in July. It was painful. The vibrations of the car, putting my hair up, and changing clothes physically hurt. I took Tylenol, Aspirin, Aleve, and finally Ibuprofen, at 5pm on Friday 1/22/21. Ibuprofen 800mg was the only thing that helped. I took it every 6 hours until I went to bed Saturday night and was fine after that.
SHAKING SO BAD COULD BARELY SPEAK; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On an unspecified date, the patient experienced shaking so bad could barely speak. The action taken with covid-19 vaccine was not applicable. The outcome of shaking so bad could barely speak was not reported. This report was non-serious.
Left upper thigh swollen to knee, light red, warm with mild induration. Rx Keflex 250 mg 2 tsp TID x 7 days
24Mar92 pt taken to ER /w temp greater than 103-pt had "jumped" in bed & then collasped-unresponsive.Pt given O2 @hosp & kept in hosp til 27Mar92. temp remained @ 103 or greater during adm, subsided /win wk.Apr92 mom repts pt had sz.
pt received Janssen vaccine around 10:28a. Patient was sitting in the post vaccination area. Around 3-5mins, he fainted, hit the floor. I ran out once this was brought to my attention. I found him on floor, blood on the floor and he was shaking and then stop. I don't know how long he was shaking but it stop. I checked the pt and he regained conciousness. I asked if he is ok. He ask what happened because he does not remember. He speaks another language and an associate was there to translate. We asked if he wants us to call 911, he refused. The firefighter/paramedics suggested they will come over anyway to make sure he is ok, he does not have to go with them to go to the hospital. Pt did not want to go to hospital because he does not have insurance. He was checked by a medic who also speaks his language. He checked pt's vital signs, asked questions like allergies, medical conditions, asked what day is today and what is his name (which were the same questions I asked before medic arrived). Medic informed patient the importance of seeing to a dr, the sooner the better. Pt still does not want to be taken to the hospital. Patient  signed a refusal form. Nephew picked up the pt
Positive rapid test for Covid 19 on 11Aug2022; Positive rapid test for Covid 19 on 11Aug2022; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 47-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 23Feb2021 as dose 1, single (Lot number: FH8030), on 16Mar2021 as dose 2, single (Lot number: EL3247) and on 26Nov2021 as dose 3 (booster), single (Lot number: EL3247) at the age of 46 years for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 10Aug2022, outcome "not recovered" and all described as "Positive rapid test for Covid 19 on 11Aug2022". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (11Aug2022) Positive, notes: Positive rapid test for Covid 19 on 11Aug2022. Therapeutic measures were not taken as a result of drug ineffective, covid-19.  Additional information: The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has been tested for COVID-19   Follow-up attempts are possible. No further information is expected.
Administered vaccine that was stored at temperature between -80 degree F to -84 degree F; Administered vaccine that was stored at temperature between -80 degree F to -84 degree F; Administered vaccine that was stored at temperature between -80 degree F to -84 degree F; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT STORAGE ERROR (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F), PRODUCT ADMINISTRATION ERROR (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) and PRODUCT TEMPERATURE EXCURSION ISSUE (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 076C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 19-Nov-2021, the patient experienced PRODUCT ADMINISTRATION ERROR (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) and PRODUCT TEMPERATURE EXCURSION ISSUE (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F). At the time of the report, PRODUCT STORAGE ERROR (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F), PRODUCT ADMINISTRATION ERROR (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) and PRODUCT TEMPERATURE EXCURSION ISSUE (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication details were not reported by the reporter. Treatment details was not reported by the reporter.
Patient given undiluted vaccine, correct volume but not diluted so patient got more than recommended dose.
Patient came to vaccination table with identification and card. Scribe received vaccination card and ID, failing to verify with the patient that they are about to receive Pfizer,  also failing to look at vaccination card which states she has previously received Moderna. Nurse administered vaccine without verifying previous vaccination was Pfizer, which it was not. Patient vaccinated without any immediate adverse reactions. Clinical lead alerted immediately. Patient left site without incident.
Information has been received from a pharmacist referring to a 66 year old female patient. The patient had none pertinent medical history or drug reactions. On 19-NOV-2015 the patient was vaccinated with a dose of ZOSTAVAX (lot # L028283, expiration ate 28-OCT-2015, 0.65 ml) subcutaneously in the back of an unspecified arm. The patient had none concomitant therapies. On 22-NOV-2015, the back of her arm was itchy around the injection site and there was a small bump underneath the skin. "Clarified with the pharmacist that the "lump" was not a rash, but an "injection site reaction.". No treatment was given for the adverse events. None lab diagnostics studies were performed. The outcome of the events was reported as not recovered/not resolved. Additional information has been requested.
Systemic: Abdominal Pain-Medium, Systemic: Dizziness / Lightheadness-Severe, Systemic: Fainting / Unresponsive-Severe, Systemic: Flushed / Sweating-Medium, Systemic: Headache-Medium, Systemic: Hypotension-Severe, Systemic: Nausea-Medium, Systemic: Shakiness-Mild, Systemic: Vomiting-Medium, Systemic: Weakness-Medium, Additional Details: Following 2nd covid-19 vaccination, patient became very lightheaded and fainted while seated in chair. After coming to again, she was very pale, having a hard time controlling her breathing and stated she couldnt see. 911 was called and upon the paramedics arriving, blood pressures both sitting and standing were taken, as well as a blood glucose reading. The patients blood pressure was low but stable, and her blood glucose reading was normal. Patient walked out of store with paramedics and Mom.
On 9-6-07 at 12:00 Pneumo vaccine given at about 11:00pm warm to touch, tender. Today right upper arm red, swelling, some itching, T 98.8, PAC notified and examined patient ice packs, Alleve, call nurse on Monday.
Student states, his hands and face began to itch approx. 15 minutes, post vax, with generalized redness. Was given Benadryl po 50mg with good results. BP-140/90; AP-90; T-98F; anxious, breathing easy. Signs and symptoms upon discharge from IZ area.
On 9/5/18 my left upper arm was swollen. 9/6/18 my mid arm had reddened area, ~3x2" with slight itching.  9/7/18 the area was slightly larger but deeper red color, itching. I took benadryl 25mg x2 that evening, then benadryl 25mg x1 the next day.
Fever, chills, aches, general fatigue, higher blood pressure. Pregnancy totally normal and due 12/25
Patient was administered Bivalent Pfizer and had one previously from another center on 9/14/22
Myalgia pain, redness, swelling, fatigue and body aches reported by receiver Narrative:
Moderna 7/22/21, 8/21/21. Positive on 2/5/22
A week after having the shot administered, site of injection became red, itchy, hard, swollen and felt slightly warm to the touch (like an infection). Arm is also sore. It has been swollen for 3 days now, so no final outcome yet.
This spontaneous report was received from a medical assistant referring to a 70 year old female patient. The patient's concurrent conditions, medical history and drug reactions / allergies were not provided. On 14-NOV-2017, by recommendation of a nurse practitioner, the patient was vaccinated with PNEUMOVAX 23, intramuscular in the right arm for prophylaxis (lot # N025384, expiry date:19-APR-2019). Concomitant therapies included aspirin (manufacturer unknown), atorvastatin, losartan potassium (manufacturer unknown), metformin, metoprolol, insulin degludec (TRESIBA) and vitamin D. On 14-NOV-2017 at night, the patient started with injection site reaction of redness and swelling from right upper arm into clavicle area (injection site swelling, injection site erythema and peripheral swelling) as reported by the Medical Assistant. On 15-NOV-2017, the patient's husband notified the physician office that besides of the right arm injection site swelling down to hand and up to shoulder, and the red site injection; the patient also had pain in the injection site (injection site pain), had numbness (hypoaesthesia) and tingling in the entire right arm (paraesthesia), difficulty at breathing (dyspnea) and at walking (gait disturbance). The patient sought medical attention by emergency room visit on 15-NOV-2017. The patient received an unspecified intravenous medication as treatment. It was unknown if laboratory diagnostics studies were performed. Finally, the medical assistant called back and reported that the patient had not experienced swelling of the fingers, shortness of breath or chest pains. The outcome of injection site swelling, peripheral swelling, injection site erythema, injection site pain, gait disturbance, dyspnoea, hypoaesthesia and paraesthesia was reported as not recovered. The causality assessment between PNEUMOVAX 23 and the aforementioned events was unknown. The reporter considered, injection site swelling, peripheral swelling, injection site erythema, injection site pain, gait disturbance, dyspnoea, hypoaesthesia and paraesthesia were medically significant events.
second dose was  more than a months after his first dose, and it had expired on the 20May2022.; he received and expired vaccine for his second dose; This spontaneous case was reported by a patient and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose was  more than a months after his first dose, and it had expired on the 20May2022.) and EXPIRED PRODUCT ADMINISTERED (he received and expired vaccine for his second dose) in a 30-year-old male patient who received mRNA-1273 (Spikevax) (batch nos. 033K21-2A and 033K21-2A) for COVID-19 vaccination.     Concurrent medical conditions included Hay fever.   On 14-Feb-2022, the patient received first dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 30-Jun-2022, received second dose of mRNA-1273 (Spikevax) (unknown route) dosage was changed to 1 dosage form. On 30-Jun-2022, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose was  more than a months after his first dose, and it had expired on the 20May2022.) and EXPIRED PRODUCT ADMINISTERED (he received and expired vaccine for his second dose). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose was  more than a months after his first dose, and it had expired on the 20May2022.) and EXPIRED PRODUCT ADMINISTERED (he received and expired vaccine for his second dose) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: (Positive) Positive.         No concomitant medication was provided. No treatment medication were provided. No other vaccines were received by the patient within 1 month prior to Moderna COVID-19 vaccine. It was reported that patient had never experienced a similar event in the past. The AE did not cause patient to seek medical care (office visit, Urgent care, ER, hospitalized). The patient had COVID + test or diagnosis in Jan2022 or Dec2021.
pain in his back; This is a spontaneous report from a contactable consumer (patient himself). A 67-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, lot number: EW0198, expiry date: unknown) via unspecified route of administration on 07Jul2021 as dose 1, single for Covid-19 immunisation. Vaccination facility type was Clinic and was not administered at Military facility. Medical history and concomitant medications were not reported. Patient stated he was getting his second dose today, and 30 minutes ago he took a 500mg acetaminophen, one tablet for pain in his back, to help ease the pain and asked if that is ok to do before the second dose? He was questioning second dose today after taking acetaminophen today also on 28Jul2021. He was scheduled to take his second dose today and he forgot. Patient had pain in his back for 3 days on 24Jul2021, Sunday. He also asked how long he should wait after one pill of 500mg of acetaminophen to take the vaccination? Patient stated that he would like to make sure, so that he doesn't make any mistakes, that it was okay to take his second dose if he took a 500mg Acetaminophen today. He denied any medical conditions, medications, labs, testing, or treatments relevant to report. He stated that he took daily medications but his doctor told him that they were safe. There was no history of all previous immunization with the Pfizer vaccine considered as suspect. No additional vaccines was administered on same date of the Pfizer suspect. There was no emergency room or physician office visit for the adverse events. There was no prior vaccinations (within 4 weeks) or other vaccinations within four weeks prior to the first administration date of the suspect vaccine. Patient stated that he doesn't know about vaccines he had as a child or a baby. He stated that he had the Tetanus Vaccine about 8 years ago with no reactions. Patient underwent lab test for height, with results as 5 foot 3 inches or 5 foot 4 inches on an unspecified date. The outcome of event was back pain was not recovered.  Follow-up attempts completed. No further information expected.  Amendment: This follow-up report is being submitted to amend previously reported information: event Circumstance or information capable of leading to medication error was deleted
Nauseated  Aching all over Injection site exploding Saw lights and couldn?t stand Couldn?t speak Couldn?t lay down Symptoms passed after about an hour and remained sore, lethargic, with headaches for about a week after Still having  headaches and lethargy
Hands and arms feel heavy, HA, patient felt like she was moving in slow motion. Cleared by EMS
Fever; Sore body; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of fever in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   In SEP-2023, the patient received Shingles vaccine. In SEP-2023, an unknown time after receiving Shingles vaccine, the patient experienced fever (Verbatim: Fever) and general body pain (Verbatim: Sore body).  The outcome of the fever and general body pain were resolving.   It was unknown if the reporter considered the fever and general body pain to be related to Shingles vaccine.     It was unknown if the company considered the fever and general body pain to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 17-SEP-2023 This case was reported by a patient via interactive digital media. The patient reported that he or she received Shingles vaccine on Monday, 3 days ago today and that's how he or she felt.  The reporter stated that they already told me that patient could get a fever and sore body these are the symptoms of the vaccine and today patient felt better. Follow-up would not possible as no contact details were available
I tested positive for covid on July 13, 2022 and so far I've experienced headache, body aches, & dry cough.
Swollen arm; This is a spontaneous report from a contactable physician received via a Pfizer sales representative. A 4-decade-old female patient received pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein) (PREVNAR 13, lot number and expiration date not provided), via an unspecified route of administration in the arm at the physician's office on 14Feb2019 at a single dose since they travel a lot and husband insisted on it. The patient's medical history and concomitant medications were not reported. The patient experienced swollen arm on 14Feb2019. The patient went back to the doctor the next day and got a steroid shot. Outcome of the event was recovered; physician was unsure when it resolved.  Information on the lot/batch number has been requested.
migraine; This is a spontaneous report from a Pfizer sponsored program. A contactable consumer reported that a male patient of an unspecified age received the first dose of BNT162B2 (also reported as Pfizer-BioNTech COVID-19 mRNA vaccine), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The reporter was asking if the patient can take rizatriptan since he experienced migraine on an unspecified date after taking his first dose of the COVID vaccine. The outcome of the event was unknown.   Information on the lot/Batch number has been requested.